← back to search

Dieter Steinhilber

Goethe University Frankfurt · DE
Area of research
Pharmacology · Genetics
Research interest
Research interests include Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Eicosanoids and Hypertension Pharmacology, and Asthma and respiratory diseases.
h-index
56
citations
12,213
works
434
NIH funding
primary concept
email

Recent publications

Technical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry
Science Signaling 2025cited by 29position: middledoi
Development of a Potent and Selective G2A (GPR132) Agonist
Journal of Medicinal Chemistry 2024cited by 2position: middledoi
Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples
Nature Communications 2023cited by 59position: middledoi
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
Frontiers in Pharmacology 2022cited by 177position: lastdoi
Iron-Dependent Trafficking of 5-Lipoxygenase and Impact on Human Macrophage Activation
Frontiers in Immunology 2019cited by 60position: middledoi
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
Journal of Medicinal Chemistry 2017cited by 81position: middledoi
Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE
Biochemical Pharmacology 2017cited by 25position: middledoi
Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
Oncotarget 2016cited by 168position: middledoi
Lipoxin and resolvin biosynthesis is dependent on 5‐lipoxygenase activating protein
The FASEB Journal 2015cited by 81position: middledoi
5-Lipoxygenase Is a Direct Target of miR-19a-3p and miR-125b-5p
The Journal of Immunology 2015cited by 59position: lastdoi
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014cited by 497position: middledoi
Vitamin D in inflammatory diseases
Frontiers in Physiology 2014cited by 282position: lastdoi
Inhibitors of the Arachidonic Acid Cascade: Interfering with Multiple Pathways
Basic & Clinical Pharmacology & Toxicology 2013cited by 133position: middledoi
Recent Advances in the Search for Novel 5‐Lipoxygenase Inhibitors
Basic & Clinical Pharmacology & Toxicology 2013cited by 127position: firstdoi
Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells
Molecular Pharmacology 2013cited by 117position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ewgenij Proschak · Goethe University Frankfurt5 papers (2013–2024)Astrid S. Kahnt · Goethe University Frankfurt3 papers (2015–2022)Garret A. FitzGerald · Dalian Medical University3 papers (2016–2023)Gerd Geißlinger · Goethe University Frankfurt3 papers (2015–2022)Olof Rådmark · Karolinska Institutet2 papers (2014–2015)Stefan Offermanns · Institute for New Media2 papers (2022–2024)Per Johan Jakobsson · Karolinska University Hospital2 papers (2022–2023)Alessandro Sgambato · Università Cattolica del Sacro Cuore2 papers (2013–2016)Sara Alberti · Ferring Pharmaceuticals (Switzerland)2 papers (2013–2016)Ann‐Kathrin Häfner · Goethe University Frankfurt2 papers (2015–2019) · 2 papers (2017–2024)Robert C. Murphy · University of Colorado Health2 papers (2022–2023)Astrid Kaiser · Goethe University Frankfurt2 papers (2017–2024)Carlo Angioni · Goethe University Frankfurt2 papers (2015–2017)Valerie B. O’Donnell · University of Colorado Denver2 papers (2022–2023)Melania Dovizio · University of Chieti-Pescara2 papers (2013–2016) · 2 papers (2022–2024)Hartmut Kühn · Charité - Universitätsmedizin Berlin2 papers (2022–2023)Paola Patrignani · University of Chieti-Pescara2 papers (2013–2016)Nils Helge Schebb · University of California, Davis2 papers (2022–2023)